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levated HCV rate is due to drug use or other putative risk behaviors remains unclear.
ethods:Recent non-injection drug users of heroin, crack and/or cocaine were street-recruited from 2000 to 2003 and underwent a
nd venipuncture for HCV antibody assays. Multiple logistic regression analyses were used to assess correlates for HCV infectio
esults:Of 740 enrollees, 3.9% were HCV positive. The median age (intraquartile range) was 30 (35–24) years, 70% were male
ere Black or Hispanic. After adjustment, HCV seropositives were significantly more likely than seronegatives to be older than 30
dds ratio (AOR) = 5.71], tattooed by a friend/relative/acquaintance [AOR = 3.61] and know someone with HCV [AOR = 4.29], but w
ikely to have shared nail or hair clippers, razors or a toothbrush [AOR = 0.32].
onclusions:Non-commercial tattooing may be a mode of HCV transmission among NIDUs and education on the potential risk
on-sterile tattooing equipment should be targeted toward this population. While no evidence was found for HCV transmission thro
quipment sharing or sexual risk behavior, further research is still warranted.
2005 Elsevier Ireland Ltd. All rights reserved.
eywords:HCV transmission; Epidemiology; Intranasal drug users; Non-injection drug use; Risk behaviors
. Introduction
While injection drug use is the major risk factor for
epatitis C virus (HCV) infection (Prevention, 1998), non-
njection drug users (i.e., intranasal heroin or cocaine users
nd crack smokers) on average have an HCV prevalence that
s higher than that of the general population (5–12% versus
%) (Abraham et al., 1999; Alter et al., 1999; Gyarmathy
t al., 2002; Hershow et al., 1998; Koblin et al., 2003;
yamathi et al., 2002; Rosenberg et al., 2001; Shirin et al.,
000; Thomas et al., 1995; Tortu et al., 2004; Van
meijden et al., 1993; Wada et al., 1999). The basis for this
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elevated prevalence is unknown, but could be due to la
recognition of typical risk factors (i.e., injection drug u
among non-injectors. In the absence of a clear parenter
posure(s), investigation of other modes of HCV transmis
is needed.
Some researchers have hypothesized that non-injecto
quire HCV as a result of non-injection drug use practices
sharing non-injecting drug equipment), personal hyg
practices (i.e., sharing razors or clippers), non-comme
tattooing and/or high-risk sexual behaviors (Conry-Cantilena
et al., 1996; Gyarmathy et al., 2002; Koblin et al., 20
McMahon et al., 2004; McMahon and Tortu, 2003; Qua
et al., 2003; Tortu et al., 2004, 2001; Neaigus et
2001). However, to date, the data for each of these
pothesized modes of transmission are conflicting an
376-8716/$ – see front matter © 2005 Elsevier Ireland Ltd. All rights reserved.
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reports have been published that have simultaneously as-
sessed these modes of transmission among non-injection drug
users (NIDUs).
The purpose of this study was to investigate the hypothe-
sis that sharing non-injecting drug equipment, high-risk sex-
ual behaviors and unhygienic practices are independently
and positively associated with HCV seropositivity among
NIDUs. These findings follow our preliminary work con-
ducted among NIDUs (Koblin et al., 2003) and includes a




Eligible NIDUs included persons 15–40 years of age in
New York City (NYC) who acknowledged non-injection
use of heroin, crack and/or cocaine at least 2–3 times in
the last 2 months, but for less than 10 years and denied a
history of injection drug use. Beginning August 2000, street-
outreach methods that built upon street-ethnography as de-
scribed elsewhere (Diaz et al., 2001) were used to recruit both
injectors (for a concurrent hepatitis C cohort study among





























non-judgmental setting which in turn facilitated more truth-
ful responses from participants. Third, data collected during
a follow-up visit regarding injection drug use history and
other eligibility criteria was double checked against baseline
data to enhance the validity of the collected baseline data
and minimize inclusion of injection drug users in the study
population.
The interview ascertained the three following main expo-
sure categories: (1) the use and sharing of non-injecting drug
equipment, (2) sexual behaviors and (3) personal hygiene.
Specifically, the use and sharing of non-injecting drug equip-
ment was ascertained by asking participants if they shared
a straw or dollar bill to sniff/snort cocaine, heroin or heroin
with cocaine in the past 6 months (and if so, whether the de-
vice was blood tinged) as well as if they ever shared a crack
pipe (and if so, whether the device was blood tinged).
High-risk sexual behaviors included ever-trading sex (i.e.,
exchanged sex for drugs/money and vice versa), ever having a
sex partner who injected drugs, ever having a sex partner who
indicated that he/she had hepatitis and ever noticing blood
during sex. HIV serostatus was also examined as a potential
covariate to provide possible evidence of sexual transmission.
Hygiene measures included ever sharing personal hy-
giene products such as toothbrushes, nail or hair clip-
pers or electric/non-electric razors. The source and/or




























i helpnjectors (HOPE study) from specific NYC neighborho
n Manhattan, Brooklyn, Queens and South Bronx kn
or high drug activity. Among NIDUs, no history of injectio
rug use (i.e., injection of illicit drugs, steroids, hormo
r any other substance) was confirmed during the socia
emographic portion of the baseline interview. Once in
ion status was determined, the participant was adminis
he appropriated survey instrument, e.g., Hep C risk su
r HOPE risk survey. The lack of antecubital track ma
bserved by the staff phlebotomist was also used to e
ish absence of injection drug use among participants at
tudy visit.
.2. Data collection
Study participants were recruited through street-outr
n ethnographically determined high drug risk neighb
oods. Potential study participants identified through st
utreach were escorted back to the research storefron
tudy mobile van to be screened for eligibility. Several s
ere taken during the study to detect and minimize den
njection history. First, the screening instrument was desi
n such a way to prevent disclosure of eligibility criteria. S
ral other studies with various eligibility criteria were be
onducted simultaneously at the same research sites a
uch, it was rare for participants to be turned away du
neligibility; this may have minimized inaccurate self-rep
f injection status to gain entrance into a study protocol.
nd, all interviews were performed in private rooms at th
earch storefront or on the study van to create a comfors
ail store, doctor’s office, friend/relative/acquaintance
rison). Finally, participants were asked if they ever li
r knew someone with HCV infection and their relati
hip with that person (i.e., husband/boyfriend/male lo
ife/girlfriend/female lover, sister/brother, daughter/s
other/father, client/casual sex partner, shooting/run
uddy, drug/needle dealer, friend/acquaintance or othe
Other relevant variables (based on previous reports
ere examined included type, frequency and duratio
rug use as well as sociodemographics such as age, g
ace, education, income, homelessness, history of meth
aintenance and prison history (Conry-Cantilena et al., 199
yarmathy et al., 2002; Koblin et al., 2003; McMahon et
004; Quaglio et al., 2003; Tortu et al., 2004, 2001).
After undergoing a 45-min interviewer-administered
erview, study participants underwent pre-test counseling
enipuncture for HIV, HBV and HCV serological testin
erological tests were conducted using commercial a
i.e., HCV Version 2.0 ELISA and Chiron RIBA HCV 3
IA) and interpreted using standard criteria. HCV seros
ollected at baseline served as the outcome measure f
nalysis.
.3. Statistical analysis
For categorical variables, proportions were calculate
escriptive statistics, while medians with intraquartile ran
ere used for continuous variables. Cross-tabulation
CV antibody status by covariates of interest were ex
ned using odds ratios with 95% confidence intervals to
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guide interpretation. Medians and/or commonly used cut
points (based on previous studies) were used to categorize
all continuous data. Multiple logistic regression with HCV
serostatus as the outcome was used to simultaneously control
for confounding and explore plausible interactions. Putative
confounders included age, race, education, prison history,
income, homelessness and drug type. Interaction terms be-
tween gender and sexual behavior variables were examined
as well as interaction between knowing someone with HCV
and the three following exposures: (1) having been tattooed
by a friend/relative/acquaintance, (2) sharing non-injecting
drug equipment and (3) high-risk sexual practices.
Given the broad scale of variables explored and the ex-
pected small number of cases of HCV, separate logistic
regression models were fitted for each of the three main ex-
posure categories of interest (the use and sharing of non-
injecting drug equipment, sexual behavior and personal
hygiene) to limit the number of variables explored simultane-
ously in a given model. All of the above-mentioned potential
confounders were explored and controlled for in each of the
three regression models as needed. In addition, for each ex-
posure category, all measures with ap-value at or below 0.2
during cross-tabulations were considered during final model
building procedures utilizing stepwise backward elimination.
Likelihood ratio tests were used to assess whether the inclu-





























Sociodemographic factors associated with HCV seropositive status among







≤30 391 (54.2) 1.5 1.00
>30 331 (45.8) 6.7 4.57*** 1.83, 11.41
Race/ethnicity
Black 304 (42.2) 3.0 1.00
Hispanic/Latino 346 (48.0) 5.5 1.90** 0.85, 4.28
White/otherb 71 (9.8) 0.0 – –
Gender
Female 212 (29.8) 5.2 1.00
Male 500 (70.2) 3.4 0.64 0.30, 1.40
Education completed
≥High school or GED 311 (43.2) 4.2 1.00
<High school 409 (56.8) 3.7 0.87 0.41, 1.86
Total yearly income
≤US$ 5000 602 (83.4) 3.8 1.00
>US$ 5000 120(16. ) 4.2 1.09 0.41, 2.94
Blood transfusion before 1991
No 713 (96.4) 3.8 1.00
Yes 27 (3.7) 3.7 0.98 0.13, 7.47
Ever been in methadone maintenance program
No 619 (83.6) 3.5 1.00
Yes 121 (16.4) 5.0 1.42 0.56, 3.57
Ever incarcerated
No 509 (68.8) 3.1 1.00
Yes 231 (31.2) 5.2 1.69 0.78, 3.63
Ever been homeless
No 149 (20.2) 3.4 1.00
Yes 590 (79.8) 3.9 1.17 0.44, 3.13
a Column does not add up to 740 due to missing data.





seropositive at baseline (OR = 2.64) and to have had a sex
partner tell them he/she had hepatitis (OR = 3.95). In terms
of other social circumstances that may indirectly contribute to
HCV infection, as shown inTable 3, HCV seropositives were
more likely than seronegatives to report knowing someone
else with HCV (OR = 3.18) and to have a friend/acquaintance
with HCV (OR = 3.32). Finally,Table 4 shows that HCV
seropositives were less likely than seronegatives to have had
a piercing from a retail store (OR = 0.31), or to have shared
nail or hair clippers, razors or a toothbrush (OR = 0.37). No
other hygiene practice examined was found to differ by HCV
serostatus.
Table 5shows as a final comprehensive model that consid-
ered each variable that significantly contributed to the final
regression model. The three logistic models corresponding
to use and sharing of non-injecting drug equipment, sexual
behavior and hygiene practices are not shown. The use and
sharing of non-injecting drug equipment as well as sexualodel. Variables that demonstrated statistical significan
ach final model were used further to build the most p
onious final model. SAS Version 9.0 was used to con
ll of the analyses.
. Results
Of the 755-recruited NIDUs, 15 subjects who respon
ith conflicting information on the risk survey regarding th
njection drug use history were excluded from the analy
fter exclusion of these 15 subjects, 28 (3.9%) of 722
icipants were HCV positive at baseline. Seventy perce
articipants were male and 90% were either Black or
anic (Table 1). The median age (interquartile range) of p
icipants was 30 (35–24) years old with approximately 5
f study subjects reporting to have completed less than a
chool education, and 84% reporting a yearly income at o
ow US$ 5000. Being older than 30 years of age (OR = 4
as the sole sociodemographic characteristic associate
CV seropositive status.
Table 2shows bivariate analyses assessing the rela
hip between drug use behaviors and HCV serostat
aseline. HCV seropositives were more likely than seron
ives to have sniffed/snorted heroin daily (OR = 2.24), to h
hared a crack pipe when blood was present (OR = 12.78
ore than twice as likely to have smoked heroin with cr
OR = 2.27). InTable 3, sexual behaviors and current H
erostatus was examined in relation to HCV serostatus.
eropositives were more likely than seronegatives to be
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Table 2
Drug use behaviors associated with HCV seropositive status among non-
injecting drug users, New York City, 2000–2003 (N= 740)
Behavior Na (%) HCV+ (%) OR 95% CI
Sniffed/snorted cocaineb
<Daily 629 (5.3) 4.3 1.00
≥Daily 93 (12.9) 1.1 0.24 0.03, 1.80
Shared straw or dollar bill to sniff/snort cocainec
No 468 (64.8) 3.6 1.00
Yes 254 (35.2) 4.3 1.20 0.55, 2.60
Sniffed/snorted heroinb
< Daily 574 (79.5) 3.1 1.00
≥ Daily 148 (20.5) 6.8 2.24** 1.01, 4.96
Shared straw or dollar bill to sniff/snort heroinc
No 592 (82.0) 4.1 1.00
Yes 130 (18.0) 3.1 0.75 0.26, 2.20
Sniffed/snorted heroin and cocainec
<Daily 545 (75.5) 3.3 1.00
≥Daily 177 (24.5) 5.6 1.75* 0.79, 3.87
Shared straw or dollar bill to sniff/snort
heroin with cocainec
No 672 (93.1) 3.7 1.00
Yes 50 (6.9) 6.0 1.65 0.48, 5.67
Smoked crackb
<Daily 565 (78.2) 4.1 1.00
≥Daily 157 (21.8) 3.2 0.77 0.29, 2.07
Shared crack pipe when blood presentc
No 717 (99.6) 3.8 1.00
Yes 3 (0.4) 33.3 12.78* 1.12, 145.29
Ever smoke heroin with crack
No 577 (81.4) 3.1 1.00
Yes 132 (18.6) 6.8 2.27** 1.00, 5.18
a Column does not add up to 740 due to missing data.
b Past 2 months.




behavior variables were not significant in their respective
logistic regression models after controlling for potentially
confounding variables, i.e., age. However, in both hygiene
and comprehensive models, being HCV seropositive was sig-
nificantly associated with being older (AOR = 5.71), having
been tattooed by a friend/relative/acquaintance (AOR = 3.61),
knowing someone with HCV (AOR = 4.29), but inversely as-
sociated with sharing nail or hair clippers, razors or a tooth-
brush (AOR = 0.32). Interaction terms did not improve the fit
of the comprehensive model.
4. Discussion
Among this NYC population of non-injecting drug users,
neither sharing of non-injecting drug equipment such as
straws and pipes nor high-risk sexual practices were asso-
ciated with HCV seropositive status. Although our bivariate
associations were suggestive of a role of these practices, these
Table 3
Sexual behaviors and social circumstances associated with HCV seropositive







No 696 (94.0) 3.6 1.00
Yes 44 (6.0) 6.8 1.96* 0.57, 6.77
Sex partner(s) with hepatitisb
No 716 (96.8) 3.5 1.00
Yes 24 (3.2) 12.5 3.95** 1.10, 14.11
Traded sexc,d
No 538 (72.7) 4.3 1.00
Yes 202 (27.3) 2.5 0.59 0.21, 1.52
HIV+
No 650 (90.2) 3.4 1.00
Yes 71 (9.8) 8.5 2.64*** 1.03, 6.73
Ever notice blood during sex
No 446 (63.2) 4.5 1.00
Yes 260 (36.8) 2.7 0.59 0.25, 1.41
Know someone with HCV
No 592 (80.0) 2.7 1.00
Yes 148 (20.0) 8.1 3.18*** 1.47, 6.87
Lived with someone with HCV
No 677 (94.2) 3.6 1.00
Yes 42 (5.8) 9.5 2.86** 0.95, 8.67
Have a friend/acquaintance with HCV
No 622 (86.8) 3.1 1.00
Yes 95 (13.2) 9.5 3.32*** 1.46, 7.58
a Column does not add up to 740 due to missing data.
b Self-report.
c Past 2 months.




associations did not persist after adjustment for age. Having
been tattooed by a friend or relative did emerge as a signif-
icant risk correlate for HCV infection as well as knowing
someone with HCV infection. Alternatively, an independent
inverse association between HCV infection and ever sharing
personal hygiene products such as nail or hair clippers, razors
or a toothbrush was observed.
In terms of non-injecting drug equipment sharing,Tortu
et al. (2004)examined risk correlates for HCV infection
among female NIDUs and found that ever sharing both oral
and intranasal non-injecting drug equipment was associated
with HCV seropositivity, whileMcMahon et al. (2004)
showed the presence of HCV RNA in the nasal secretions
of an intranasal drug user. These findings provide evidence
for sharing non-injecting drug equipment as a plausible
mechanism for HCV transmission. However, similar to our
study,Gyarmathy et al. (2002)did not find an association
between equipment sharing and HCV seroprevalence in their
study among non-injecting heroin users. It is plausible that
differences in the way that non-injecting drug equipment
sharing was measured in the above-mentioned studies con-
C.J. Howe et al. / Drug and Alcohol Dependence 79 (2005) 389–395 393
Table 4
Hygiene practices associated with HCV seropositive status among non-injecting drug users, New York City, 2000–2003 (N= 740)
Practice Na (%) HCV+ (%) OR 95% CI
Source of tattoo
No tattoo 443 (62.6) 3.4 1.00
Retail store 90 (12.7) 2.2 0.65 0.15, 2.89
Friend/relative/acquaintance 69 (9.7) 7.3 2.23* 0.78, 6.34
Prison 106 (15.0) 3.8 1.13 0.36, 3.44
Source of piercing
No piercing 216 (29.2) 6.0 1.00
Doctor’s office 3 (0.4) 0.0 – –
Retail store 305 (41.2) 2.0 0.31*** 0.12, 0.83
Friend/relative/acquaintance 194 (26. ) 4.1 0.67 0.27, 1.66
Prison 22 (3.0) 4.5 0.74 0.09, 5.97
Ever share electric razor
No 657 (91.1) 3.6 1.00
Yes 64 (8.9) 6.2 1.75 0.59, 5.23
Ever share non-electric razor
No 642 (89.0) 4.0 1.00
Yes 79 (11.0) 2.5 0.61 0.14, 2.64
Ever share nail or hair clippers
No 400 (55.5) 5.3 1.00
Yes 321 (44.5) 2.2 0.40** 0.17, 0.96
Ever share toothbrush
No 668 (92.6) 3.7 1.00
Yes 53 (7.4) 5.7 1.54 0.45, 5.29
Ever share razor or hair clippers or nail clippers or toothbrush
No 386 (53.5) 5.4 1.00
Yes 335 (46.5) 2.1 0.37*** 0.15, 0.88




tributed to conflicting study results. Establishing accurate
and uniform non-injecting equipment sharing measures
could perhaps reconcile these study differences. Conducting
qualitative research involving the actual practices and the
social context in which equipment sharing is practiced
may help with identifying such measures. Thus, further
investigation of HCV transmission through non-injection
equipment sharing is still warranted.
Also noteworthy is the lower HCV prevalence observed
among this study sample as compared to other observed
NIDU populations (5–12% versus 3.9%) (Abraham et al.,
1999; Alter et al., 1999; Gyarmathy et al., 2002; Hershow
et al., 1998; Koblin et al., 2003; Nyamathi et al., 2002; Rosen-
berg et al., 2001; Shirin et al., 2000; Thomas et al., 1995;
Tortu et al., 2004; Van Ameijden et al., 1993; Wada et al.,
1999). This difference in HCV prevalence is likely attributed
to the fact that NIDUs in this study tended to be younger than
NIDU respondents in prior studies. Evidence of the link be-
tween younger age and HCV prevalence among NIDUs was
observed in our study and others (Tortu et al., 2004).
The absence of an association between HCV infection and
high-risk sexual behavior was observed in this NIDU popu-
lation, including the absence of interactions by gender. These
findings concur with the Centers for Disease Control and
Table 5
Multiple logistic regression of the relationship between three primary exposure categories and HCV seropositive status among non-injecting drug users, New
York City, 2000–2003 (N= 740)
Predictor Crude OR (95% CI) Adjusted ORa (95% CI)
>30 years old vs.≤30 years old 4.57*** (1.91, 12.28) 5 .71*** (2.04, 15.95)
Tattooed by a friend/relative/acquaintance vs. no tattoo 2.27* (0.80, 6.46) 3.61*** (1.15, 11.26)
Ever share razor or hair clippers or nail clippers or toothbrush vs. never 0.37*** (0.15, 0.88) 0.32*** (0.17, 0.81)
Know someone with HCV vs. not 3.18*** (1.47, 6.87) 4.29*** (1.84, 10.00)
a Adjusted for age, race, education, prison history, income and drug type.
* p< 0.20.
*** p< 0.05.
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Prevention’s assertion that “sexual transmission of HCV ap-
pears to occur, but that the virus is inefficiently spread through
this manner” (Prevention, 1998). However, whether the ab-
sence of evidence supporting sexual transmission in this study
was due to underreporting of sexual risks or sexual transmis-
sion being masked by other concurrent risk behaviors not
captured in this study is unknown. When participants were
asked about sexual behavior, they were informed that “having
sex” was defined as anal, oral and vaginal sex. Thus, we were
unable to measure the effect of anal sex on HCV seropositive
status. Future HCV research of both sexual and equipment
sharing among NIDUs should include measurement of
social desirability to offer evidence of possible underre-
porting of sexual behaviors (Latkin and Vlahov, 1998;
Latkin et al., 1993).
The potential for personal hygiene practices to contribute
to HCV transmission surfaces from this study. Consistent
with previous research (Gyarmathy et al., 2002; Hellard
et al., 2004; Ko et al., 1992; Post et al., 2001; Samuel
et al., 2001), a positive association between HCV infection
and having been tattooed by a friend or relative was observed.
Haley and Fischer (2001)conducted a study among patients
visiting an orthopedic spinal clinic who were unaware of their
HCV status and estimated that non-commercial tattooing ac-
counted for 11% of HCV infections. The fact that approxi-































might be viewed. Unfortunately, the data collected are insuf-
ficient to make clear this distinction, which emphasizes the
need for additional studies that capture varying levels of low
SES as well as access to these items.
Although this study was a large NIDU study, possibly
the largest to date among NIDU studies investigating HCV
transmission, several limitations should be acknowledged.
Using a cross-sectional design prevents temporality of asso-
ciations from being determined. Also, the extent to which
results from this study can be generalized to other drug users
is unknown. Another limitation pertains to the use of compre-
hensive measures of sexual behavior instead of type specific
variables (i.e., anal sex versus oral sex versus vaginal sex)
that may better elucidate the relationship between sexual be-
havior, particularly anal sex and HCV transmission.
In addition, the use of non-injection equipment sharing
measures pertaining to the last 6 months may not be the best
measure of non-injection equipment sharing practices. Fur-
thermore, even though steps were taken to help reduce the
potential for inclusion of injectors in this study, the strong
link between HCV infection and injection drug use would
indicate that even the slightest occurrence of misclassifica-
tion of injection history could alter our estimates. Therefore,
future research that includes circumstances that contribute
to denial of injection status among NIDUs is needed so that






























q tiony a friend or relative coupled with the strong indepen
ssociation between non-commercial tattooing and HC
ection, underscores the need for future research to d
ine public health risk of non-commercial tattooing am
his population and other populations that may obtain ta
rom non-commercial settings.
Contrary to what may have been expected, an inde
ent inverse association of ever sharing nail or hair clipp
azors or a toothbrush with HCV infection was observ
e originally considered this type of casual contact as
ng sufficient for HCV transmission given the high e
iency of transmission of HCV (Hagan and Des Jarla
000). However, a significant protective effect for shar
ersonal hygiene products persisted in this analysis, w
ould perhaps be explained by residual confounding b
ioeconomic status (SES). While we attempted to contro
ducation, homelessness and income, the level of refine
f these SES variables may have been insufficient to diffe
iate the varying levels of the extreme low SES that chara
zed this study population. For example, NIDUs who do
hare personal hygiene products may represent a rela
ow SES subgroup that may not have access to such i
lternatively, those who share and have access to razor
oothbrushes may be of a higher SES. Thus, members of
isk networks may be less likely to be HCV positive, and
onverse may be the case for higher risk networks. Co
ring the lack of sharing personal hygiene items is inde
roxy measure of SES and not a direct measure of sharin
entially HCV infected hygiene products would change h
he association between personal hygiene and HCV infeevelopment) and analysis (e.g., adjusting for potential
ounders, sample restriction based on indicators of prev
njection) can be employed to better address HCV risk am
on-injectors.
In summary, non-injecting drug use equipment sha
ay still remain as a plausible route for HCV transm
ion, even though an association between HCV infection
haring non-injecting drug equipment did not persist in
tudy population. More refined measures of non-injec
rug equipment sharing such as frequency and durati
hese practices as well as the social context in which
ehaviors tend to occur should be explored among larger
les of drug users by drug type and route of administra
i.e., crack smokers only and/or snorters). This study fo
o direct evidence for sexual transmission of HCV, yet
onceivable that the emergence of knowing someone
CV as a significant risk correlate for HCV infection m
eep the door open to consideration of sexual transmiss
CV as well as other potentially sensitive information. Gi
hat non-commercial tattooing did emerge as a potential m
f HCV transmission among NIDUs and is consistent w
rior studies (Gyarmathy et al., 2002; Hellard et al., 2004;
t al., 1992; Post et al., 2001; Samuel et al., 2001; Haley
ischer, 2001), public health educational efforts should
ndertaken among this population regarding the potenti
CV transmission when using non-sterile tattooing eq
ent. Future studies aimed at identifying hygiene, sexua
quipment sharing risk correlates for HCV infection am
ulnerable populations of NIDUs should qualitatively a
uantitatively examine the setting/practice of non-injec
C.J. Howe et al. / Drug and Alcohol Dependence 79 (2005) 389–395 395
drug use, access to and sharing of hygiene products, and the
role of sexual risk in the presence of each potential mode of
HCV transmission.
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